Metoprolol succinate and Palmar erythema - a phase IV clinical study of FDA data

Summary:

No or few reports are found.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 03, 2023

No or few reports are found.

What is Metoprolol Succinate?

Metoprolol succinate has active ingredients of metoprolol succinate. It is used in high blood pressure. Currently, eHealthMe is studying from 61,544 Metoprolol succinate users.

What is Palmar Erythema?

Palmar erythema (reddening of the palms at the thenar and hypothenar eminences) is found to be associated with 664 drugs and 350 conditions by eHealthMe. Currently, we are studying 1,355 people who have Palmar erythema.

Do you take Metoprolol succinate and have Palmar erythema?

Check whether Palmar erythema is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Metoprolol succinate side effects by duration, gender and age:

Metoprolol succinate side effects (61,544 reports)

Palmar erythema treatments and more:

Palmar erythema (1,355 reports)

All the drugs that are associated with Palmar erythema:

Palmar erythema

All the conditions that are associated with Palmar erythema:

Palmar erythema

How the study uses the data?

The study uses data from the FDA. It is based on metoprolol succinate (the active ingredients of Metoprolol succinate) and Metoprolol succinate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.